Opinion
Video
Author(s):
Key opinion leaders examine safety concerns and adverse event trends in psoriasis treatments, discussing how these factors influence decisions to discontinue therapy and transition patients to alternative interventions.
Patient-Reported Outcomes and Treatment Switching in Plaque Psoriasis
The Cutaneous Connection: An Inside Look of the Inclusive Atlas
Dermatology Times Hosts Inaugural Horizons in Advanced Practice Meeting
The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
ICYMI: FDA Greenlights Yesintek, Sixth Biosimilar to Stelara, for Psoriasis and Psoriatic Arthritis
Johnson & Johnson Submits 2 sBLAs for Guselkumab for Pediatric Psoriasis and Juvenile PsA